|
Gene Information
Gene symbol: FEV
Gene name: FEV (ETS oncogene family)
HGNC ID: 18562
Synonyms: Pet-1
Related Genes
Related Sentences
# |
PMID |
Sentence |
1 |
16740022
|
Patients treated with inhaled human insulin demonstrated a greater decline in pulmonary function (forced expiratory volume in 1 second [FEV(1)], carbon monoxide diffusing capacity [DL(CO)]) than patients treated with comparator antihyperglycaemic agents; the mean difference between the treatment groups that favoured the comparators was noted within the first several weeks of treatment, and did not change over a 2-year treatment period.
|
2 |
17563309
|
Inhaled insulin is associated with small, consistent reductions in lung function, primarily forced expiratory volume in 1 s (FEV(1)) and diffusion capacity for carbon monoxide (DL(CO)).
|
3 |
19027279
|
The FEV(1) decline was related to the following clinical characteristics: CFTR genotype, age, gender, weight, height, age at diagnosis, baseline FEV(1), pancreatic function, presence of airway infection, pancreatic insufficiency and diabetes, number of exacerbations/year and intravenous (i.v.) antibiotic courses/year.
|
4 |
19800211
|
Mainly abdominal circumference, and also insulin resistance were retained as independent predictors of both FEV(1) and FVC changes.
|
5 |
20006363
|
In Pearson and partial correlation analyses, white blood cell counts and C-reactive protein concentrations were both found to be significantly and negatively correlated with FEV(1).
|
6 |
20066539
|
FEV(1), RV, PaO(2), and PaCO(2) were used to develop an index of respiratory functional impairment (REFI index).
|
7 |
20066539
|
Mortality risk depended on age, current smoking, FEV(1), PaO(2), the REFI index, the presence of cor pulmonale, ischemic heart disease, and lung cancer.
|
8 |
20066539
|
FEV(1), RV, PaO(2), and PaCO(2) were used to develop an index of respiratory functional impairment (REFI index).
|
9 |
20066539
|
Mortality risk depended on age, current smoking, FEV(1), PaO(2), the REFI index, the presence of cor pulmonale, ischemic heart disease, and lung cancer.
|
|